Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Ventricular arrhythmia in a male MS patient on fingolimod.
[The Effect of the Disease Duration on the Changes of the Visual Evoked Potentials and Contrast Sensitivity in Multiple Sclerosis].
Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol.
Postural Motor Learning Deficits in People With MS in Spatial but Not Temporal Control of Center of Mass.
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.
Including a subject-paced trial may make the PASAT more acceptable for MS patients.
MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis.
Cognitive and psychiatric comorbidities in neuromyelitis optica.
[Is it always useful to perform lumbar puncture for the diagnosis of multiple sclerosis? Comment].
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives.
Recent advances and future challenges in the genetics of multiple sclerosis.
Progress in multiple sclerosis genetics.
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
Progressive multiple sclerosis does not associate with rs996343 and rs2046748.
EphB3 receptors function as dependence receptors to mediate oligodendrocyte cell death following contusive spinal cord injury.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: No.
The many faces of impaired bladder emptying.
Depletion of Olig2 in oligodendrocyte progenitor cells infected by Theiler's murine encephalomyelitis virus.
IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.
Analysis of CYP27B1 in multiple sclerosis.
Options in improving respiratory function in multiple sclerosis.
The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases.
PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model.
Predictors of quality of life in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.

Pages